HIV therapeutic vaccine enhances non-exhausted CD4(+) T cells in a randomised phase 2 trial.

Vieillard V, Combadière B, Tubiana R, Launay O, Pialoux G, Cotte L, Girard PM, Simon A, Dudoit Y, Reynes J, Rockstroh J, Garcia F, Gatell J, Devidas A, Yazdanpanah Y, Weiss L, Fätkenheuer G, Autran B, Joyeux D, Gharakhanian S, Debré P, Katlama C

Open source

DOI
10.1038/s41541-019-0117-5
Published
2019
Container
NPJ vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41541-019-0117-5,
  title = {HIV therapeutic vaccine enhances non-exhausted CD4(+) T cells in a randomised phase 2 trial.},
  author = {Vieillard V and Combadière B and Tubiana R and Launay O and Pialoux G and Cotte L and Girard PM and Simon A and Dudoit Y and Reynes J and Rockstroh J and Garcia F and Gatell J and Devidas A and Yazdanpanah Y and Weiss L and Fätkenheuer G and Autran B and Joyeux D and Gharakhanian S and Debré P and Katlama C},
  year = {2019},
  journal = {NPJ vaccines},
  doi = {10.1038/s41541-019-0117-5},
  url = {https://doi.org/10.1038/s41541-019-0117-5}
}

RIS

TY  - JOUR
TI  - HIV therapeutic vaccine enhances non-exhausted CD4(+) T cells in a randomised phase 2 trial.
AU  - Vieillard V
AU  - Combadière B
AU  - Tubiana R
AU  - Launay O
AU  - Pialoux G
AU  - Cotte L
AU  - Girard PM
AU  - Simon A
AU  - Dudoit Y
AU  - Reynes J
AU  - Rockstroh J
AU  - Garcia F
AU  - Gatell J
AU  - Devidas A
AU  - Yazdanpanah Y
AU  - Weiss L
AU  - Fätkenheuer G
AU  - Autran B
AU  - Joyeux D
AU  - Gharakhanian S
AU  - Debré P
AU  - Katlama C
PY  - 2019
JO  - NPJ vaccines
DO  - 10.1038/s41541-019-0117-5
UR  - https://doi.org/10.1038/s41541-019-0117-5
ER  - 

APA

V, V., B, C., R, T., O, L., G, P., L, C., PM, G., A, S., Y, D., J, R., J, R., F, G., J, G., A, D., Y, Y., L, W., G, F., B, A., D, J., S, G., P, D., & C, K. (2019). HIV therapeutic vaccine enhances non-exhausted CD4(+) T cells in a randomised phase 2 trial.. NPJ vaccines. https://doi.org/10.1038/s41541-019-0117-5

Source records